Skip to content
★ Sign in to follow
JA

Joseph Anderson

Arix Bioscience plc
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€130k
▼ Sales (0 ops.)
—

Latest filing published 11 Jun 2018 for Arix Bioscience plc.

Filing timeline

BuySale
Joseph Anderson

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Joseph Anderson: trading record in brief

Joseph Anderson is a declared insider of Arix Bioscience plc, with filings sourced from RNS (LSE). The record holds 3 filings, for trades running from 26 May 2017 to 7 June 2018.

No open-market sale appears; the market trades are 1 purchase worth €130k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 option exercises.

Most recently, on 11 June 2018, the filings show an option exercise in Arix Bioscience plc. The clock since the last published purchase (5 June 2017) now reads 3,443 days. Typically, a trade is published a median of 4 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Joseph Anderson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ◇
    Chief Executive OfficerExecutivesArix Bioscience plc
    0FCA-NSM
    373,134 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-0
  • ▲
    Chief Executive OfficerExecutivesArix Bioscience plc
    113,355 GBP45FCA-NSM
    55,000 shares@ £2.061100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20170605070004_13248596_20200330131521973_2859-0
    Canonical exit: 31 Aug 2017 (T+90)
  • ◇
    Chief Executive OfficerExecutivesArix Bioscience plc
    0FCA-NSM
    569,619 sharesOutside of a trading venueISIN GB00BD045071FCA-NSM:LSE20170530070012_13241449_20200330131531495_22267-0

3 of 3 declarations